Literature DB >> 32627827

Interactions of microorganisms with host mucins: a focus on Candida albicans.

Ashley Valle Arevalo1,2, Clarissa J Nobile1.   

Abstract

Mucus is an important host innate defense factor that lines most epithelial cell layers of the body and provides crucial physical and biological protection against pathogenic microorganisms. Mucins are the main glycoproteins of mucus that are responsible for interacting with microorganisms and are critical for the antimicrobial properties of mucus. The mechanisms by which microorganisms interact with mucins are poorly understood, especially in terms of fungi, and these interactions are continually evolving. Work in bacterial pathogens has shown that mucins inhibit bacterial virulence traits, including quorum sensing, toxin secretion and biofilm formation. Among the fungal clade, the common opportunistic human fungal pathogen and commensal Candida albicans engages in constant battle with the host innate immune system. This battle creates strong selective pressures for C. albicans to evolve in response to the host. Recent work in C. albicans found that mucins inhibit specific virulence traits, such as surface adherence, filamentation, biofilm formation and the production of secreted proteases. Here we review the current knowledge of microbial interactions with mucins, with a special emphasis on the interactions between C. albicans and mucins. © FEMS 2020.

Entities:  

Keywords:  zzm321990 Candida albicanszzm321990 ; biofilms; epithelial cell layer; host–pathogen interactions; innate immunity; mucin monomer; mucins; mucosal surface; mucus; viscoelasticity

Mesh:

Substances:

Year:  2020        PMID: 32627827      PMCID: PMC7476774          DOI: 10.1093/femsre/fuaa027

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  116 in total

Review 1.  Barrier properties of mucus.

Authors:  Richard A Cone
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

2.  Differential response of gel-forming mucins to pathogenic middle ear bacteria.

Authors:  Joseph E Kerschner; Wenzhou Hong; Pawjai Khampang; Nikki Johnston
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-06-06       Impact factor: 1.675

3.  Mucin biopolymers prevent bacterial aggregation by retaining cells in the free-swimming state.

Authors:  Marina Caldara; Ronn S Friedlander; Nicole L Kavanaugh; Joanna Aizenberg; Kevin R Foster; Katharina Ribbeck
Journal:  Curr Biol       Date:  2012-11-08       Impact factor: 10.834

4.  Viscoelastic properties and dynamics of porcine gastric mucin.

Authors:  Jonathan Celli; Brian Gregor; Bradley Turner; Nezam H Afdhal; Rama Bansil; Shyamsunder Erramilli
Journal:  Biomacromolecules       Date:  2005 May-Jun       Impact factor: 6.988

5.  Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.

Authors:  J F Staab; S D Bradway; P L Fidel; P Sundstrom
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

Review 6.  Structure and function of the polymeric mucins in airways mucus.

Authors:  David J Thornton; Karine Rousseau; Michael A McGuckin
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

Review 7.  Pathogenesis of Fungal Infections in Cystic Fibrosis.

Authors:  Craig Williams; Ranjith Ranjendran; Gordon Ramage
Journal:  Curr Fungal Infect Rep       Date:  2016-12-07

Review 8.  Protective Microbiota: From Localized to Long-Reaching Co-Immunity.

Authors:  Lynn Chiu; Thomas Bazin; Marie-Elise Truchetet; Thierry Schaeverbeke; Laurence Delhaes; Thomas Pradeu
Journal:  Front Immunol       Date:  2017-12-07       Impact factor: 7.561

9.  MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.

Authors:  Sara K Lindén; Yong H Sheng; Alison L Every; Kim M Miles; Emma C Skoog; Timothy H J Florin; Philip Sutton; Michael A McGuckin
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

Review 10.  Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila.

Authors:  Patrice D Cani; Willem M de Vos
Journal:  Front Microbiol       Date:  2017-09-22       Impact factor: 5.640

View more
  3 in total

1.  Mucin O-glycans are natural inhibitors of Candida albicans pathogenicity.

Authors:  Julie Takagi; Kazuhiro Aoki; Bradley S Turner; Sabrina Lamont; Sylvain Lehoux; Nicole Kavanaugh; Megha Gulati; Ashley Valle Arevalo; Travis J Lawrence; Colin Y Kim; Bhavya Bakshi; Mayumi Ishihara; Clarissa J Nobile; Richard D Cummings; Daniel J Wozniak; Michael Tiemeyer; Rachel Hevey; Katharina Ribbeck
Journal:  Nat Chem Biol       Date:  2022-06-06       Impact factor: 16.174

Review 2.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

3.  Epithelial Infection With Candida albicans Elicits a Multi-System Response in Planarians.

Authors:  Eli Isael Maciel; Ashley Valle Arevalo; Benjamin Ziman; Clarissa J Nobile; Néstor J Oviedo
Journal:  Front Microbiol       Date:  2021-01-14       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.